Usefulness of a new inflammation-based scoring system for prognostication of patients with hepatocellular carcinoma after hepatectomy
Abstract Background We investigated whether a preoperative scoring system (the “CRP-AFP Score [CAS]”) based on the serum levels of C-reactive protein and alpha-fetoprotein would predict outcome in patients undergoing hepatectomy for hepatocellular carcinoma. Methods The CAS was defined as follows: p...
Gespeichert in:
Veröffentlicht in: | The American journal of surgery 2015-01, Vol.209 (1), p.187-193 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Abstract Background We investigated whether a preoperative scoring system (the “CRP-AFP Score [CAS]”) based on the serum levels of C-reactive protein and alpha-fetoprotein would predict outcome in patients undergoing hepatectomy for hepatocellular carcinoma. Methods The CAS was defined as follows: patients with an elevated level of both C-reactive protein (>.3 mg/dL) and alpha-fetoprotein (>20 ng/mL) were assigned a score of 2, and patients showing one or none of these abnormalities were assigned a score of 1 or 0, respectively. Results A total of 349 patients were identified. Pathologic findings, in terms of tumor size, histologic grade, vascular invasion, intrahepatic metastasis, and recurrence rate, worsened as the CAS increased. CAS 2 patients had a poorer 5-year overall survival than CAS 0 or 1 patients (32.2% vs 59.7% vs 49.2%, respectively; P < .001). Conclusions The CAS is an informative scoring system that can predict outcome in patients with hepatocellular carcinoma after hepatectomy. |
---|---|
ISSN: | 0002-9610 1879-1883 |
DOI: | 10.1016/j.amjsurg.2014.02.015 |